These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 30682490)
1. Utilization of Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectomy. Hawken SR; Spratt DE; Qi J; Linsell SM; Cher ML; Ghani KR; Miller DC; Montie JE; Morgan TM; Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1030-1034. PubMed ID: 30682490 [TBL] [Abstract][Full Text] [Related]
2. Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy. Morgan TM; Hawken SR; Ghani KR; Miller DC; Feng FY; Linsell SM; Salisz JA; Gao Y; Montie JE; Cher ML Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):216-21. PubMed ID: 26951715 [TBL] [Abstract][Full Text] [Related]
3. Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy : Informing the debate. Budäus L; Schiffmann J; Graefen M; Huland H; Tennstedt P; Siegmann A; Böhmer D; Budach V; Bartkowiak D; Wiegel T Strahlenther Onkol; 2017 Sep; 193(9):692-699. PubMed ID: 28470414 [TBL] [Abstract][Full Text] [Related]
4. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249 [TBL] [Abstract][Full Text] [Related]
5. Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression. Lohm G; Neumann K; Budach V; Wiegel T; Hoecht S; Gollrad J Strahlenther Onkol; 2018 Apr; 194(4):325-332. PubMed ID: 29255924 [TBL] [Abstract][Full Text] [Related]
6. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics? Viani GA; Hamamura AC; Correa AC; de Arruda FT Int Braz J Urol; 2019; 45(2):237-245. PubMed ID: 30676298 [TBL] [Abstract][Full Text] [Related]
7. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy. Geinitz H; Riegel MG; Thamm R; Astner ST; Lewerenz C; Zimmermann F; Molls M; Nieder C Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1930-7. PubMed ID: 21514736 [TBL] [Abstract][Full Text] [Related]
11. The PSA-response to salvage radiotherapy after radical prostatectomy correlates with freedom from progression and overall survival. Bartkowiak D; Bottke D; Thamm R; Siegmann A; Hinkelbein W; Wiegel T Radiother Oncol; 2016 Jan; 118(1):131-5. PubMed ID: 26653358 [TBL] [Abstract][Full Text] [Related]
12. Undetectable PSA predicts outcome after salvage radiotherapy for biochemical recurrence following radical prostatectomy. Scharl S; Gartner L; Böhmer DHG; Siegmann A; Thamm R; Krafcsik M; Mayer B; Zips D; Ruf C; Wiegel T Radiother Oncol; 2024 Nov; 200():110476. PubMed ID: 39147035 [TBL] [Abstract][Full Text] [Related]
13. Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing? Tay KJ; Polascik TJ; Howard LE; Salama JK; Schulman AA; Chen Z; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ Clin Genitourin Cancer; 2019 Oct; 17(5):e930-e938. PubMed ID: 31257075 [TBL] [Abstract][Full Text] [Related]
14. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study. Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539 [TBL] [Abstract][Full Text] [Related]
15. Salvage radiation therapy following radical prostatectomy. A national Danish study. Ervandian M; Høyer M; Petersen SE; Sengeløv L; Hansen S; Holmberg M; Sveistrup J; Meidahl Petersen P; Borre M Acta Oncol; 2016 May; 55(5):598-603. PubMed ID: 26399602 [TBL] [Abstract][Full Text] [Related]
16. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Kupelian PA; Katcher J; Levin HS; Klein EA Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811 [TBL] [Abstract][Full Text] [Related]
17. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy. Tilki D; Preisser F; Tennstedt P; Tober P; Mandel P; Schlomm T; Steuber T; Huland H; Schwarz R; Petersen C; Graefen M; Ahyai S BJU Int; 2017 May; 119(5):717-723. PubMed ID: 27743493 [TBL] [Abstract][Full Text] [Related]
19. Salvage radiation therapy for prostate cancer patients after prostatectomy. Mima T; Ohori M; Hirasawa Y; Mikami R; Arai A; Hashimoto T; Satake N; Gondo T; Nakagami Y; Namiki K; Tokuuye K; Ohno Y Jpn J Clin Oncol; 2019 Mar; 49(3):281-286. PubMed ID: 30608594 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Taylor N; Kelly JF; Kuban DA; Babaian RJ; Pisters LL; Pollack A Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):755-63. PubMed ID: 12788182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]